138 related articles for article (PubMed ID: 11475344)
1. Association of hypertriglyceridemia and insulin resistance in uremic patients undergoing CAPD.
Cheng SC; Chu TS; Huang KY; Chen YM; Chang WK; Tsai TJ; Wu KD
Perit Dial Int; 2001; 21(3):282-9. PubMed ID: 11475344
[TBL] [Abstract][Full Text] [Related]
2. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
3. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
Tsao YT; Hsu YJ; Chu NF; Lai CH; Chiu JS; Lin SH
J Nephrol; 2008; 21(5):744-52. PubMed ID: 18949730
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hyperlipidemia in a cohort of CAPD patients. Italian Cooperative Peritoneal Dialysis Study Group (ICPDSG).
Cocchi R; Viglino G; Cancarini G; Catizone L; Favazza A; Tommasi A; Salomone M; Segoloni GP; Torpia R; Giangrande A
Miner Electrolyte Metab; 1996; 22(1-3):22-5. PubMed ID: 8676819
[TBL] [Abstract][Full Text] [Related]
5. Hepatic subcapsular steatosis as a complication associated with intraperitoneal insulin treatment in diabetic peritoneal dialysis patients.
Torun D; Oguzkurt L; Sezer S; Zumrutdal A; Singan M; Adam FU; Ozdemir FN; Haberal M
Perit Dial Int; 2005; 25(6):596-600. PubMed ID: 16411528
[TBL] [Abstract][Full Text] [Related]
6. Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients.
Canbakan M; Sahin GM
Ren Fail; 2007; 29(3):289-93. PubMed ID: 17497442
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
[TBL] [Abstract][Full Text] [Related]
8. Residual renal function affects lipid profile in patients undergoing continuous ambulatory peritoneal dialysis.
Kagan A; Elimalech E; Lemer Z; Fink A; Bar-Khayim Y
Perit Dial Int; 1997; 17(3):243-9. PubMed ID: 9237284
[TBL] [Abstract][Full Text] [Related]
9. Glucose tolerance in patients undergoing continuous ambulatory peritoneal dialysis.
Lindholm B; Karlander SG
Acta Med Scand; 1986; 220(5):477-83. PubMed ID: 3544691
[TBL] [Abstract][Full Text] [Related]
10. The effect of icodextrin and glucose-containing solutions on insulin resistance in CAPD patients.
Gürsu EM; Ozdemir A; Yalinbas B; Gürsu RU; Canbakan M; Güven B; Atasoyu EM; Keskin AT; Elçi A; Baru Y
Clin Nephrol; 2006 Oct; 66(4):263-8. PubMed ID: 17063993
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone improves glucose metabolism in nondiabetic uremic patients on CAPD.
Lin SH; Lin YF; Kuo SW; Hsu YJ; Hung YJ
Am J Kidney Dis; 2003 Oct; 42(4):774-80. PubMed ID: 14520628
[TBL] [Abstract][Full Text] [Related]
12. Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis.
Siamopoulos KC; Elisaf MS; Bairaktari HT; Pappas MB; Sferopoulos GD; Nikolakakis NG
Perit Dial Int; 1995; 15(8):342-7. PubMed ID: 8785232
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
[TBL] [Abstract][Full Text] [Related]
14. The uremic dyslipidemia: a cross-sectional and longitudinal study.
Avram MM; Goldwasser P; Burrell DE; Antignani A; Fein PA; Mittman N
Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199
[TBL] [Abstract][Full Text] [Related]
15. Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study.
Salomaa VV; Tuomilehto J; Jauhiainen M; Korhonen HJ; Stengård J; Uusitupa M; Pitkanen M; Penttila I
Diabetes Care; 1992 May; 15(5):657-65. PubMed ID: 1516486
[TBL] [Abstract][Full Text] [Related]
16. Effect of lovastatin on serum lipid profile in the treatment of dyslipoproteinaemia in uraemic patients on continuous ambulatory peritoneal dialysis.
Li PK; Mak TW; Chiu K; Mak GY; Leung CB; Lui SF; Lam CW; Lai KN
Aust N Z J Med; 1993 Jun; 23(3):252-7. PubMed ID: 8352699
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis.
Díez JJ; Iglesias P; Sastre J; Aguilera A; Bajo MA; Méndez J; Gómez Pan A; Selgas R
Metabolism; 1999 Feb; 48(2):210-6. PubMed ID: 10024084
[TBL] [Abstract][Full Text] [Related]
18. Hypertriglyceridemia is associated with increased insulin resistance in subjects with normal glucose tolerance: evaluation in a large cohort of subjects assessed with the 1999 World Health Organization criteria for the classification of diabetes.
Moro E; Gallina P; Pais M; Cazzolato G; Alessandrini P; Bittolo-Bon G
Metabolism; 2003 May; 52(5):616-9. PubMed ID: 12759893
[TBL] [Abstract][Full Text] [Related]
19. Twenty-four hour hormonal and metabolic profiles in uraemic patients before and during treatment with continuous ambulatory peritoneal dialysis.
Heaton A; Johnston DG; Haigh JW; Ward MK; Alberti KG; Kerr DN
Clin Sci (Lond); 1985 Oct; 69(4):449-57. PubMed ID: 4042546
[TBL] [Abstract][Full Text] [Related]
20. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients.
Balaskas EV; Bamihas GI; Karamouzis M; Voyiatzis G; Tourkantonis A
Nephron; 1998; 78(4):395-402. PubMed ID: 9578065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
